Evidence from multiple positive trials, support from literature reviews and editorials, and the endorsements of professional societies and funding agencies all promote the use of patient-reported outcomes (PROs) in clinical cancer care.
Cannabis use in Western medicine was initially popularized by Irish physician William B. O’Shaughnessy in 1840. It was included in the U.S. Pharmacopeia shortly afterward and was often prescribed for rheumatism, cholera, tetanus, rabies, and labor pain.
ASCO has published a guideline on preventing and monitoring cardiac dysfunction in survivors of adult cancers, stressing that health care providers need to initiate the discussion about potential cardiac-related toxicities before cancer treatment begins.
Authors discuss the state of international quality standards for cancer care—particularly in Spain—and how the ECO Foundation and ASCO’s Quality Oncology Practice Initiative are working to continue improving them.
ASCO is keenly aware of the need for easily accessible, physician-approved resources to help oncology care teams and their patients make informed decisions about weight management after a cancer diagnosis.
During “Constructing a Care Team for Under-Resourced Populations: Reaching the Hard-to-Reach with a Multidisciplinary Approach,” speakers will discuss how to leverage resources and provide high-quality care against a backdrop of limited time, funds, and personnel.
Palliative radiotherapy effectively eases cancer-related symptoms, but how palliative radiation therapy should be delivered—including treatment intensity and degree of technological sophistication in dose delivery—is often debated.
Dr. Stephen T. Sonis discusses advances in the science, epidemiology, and pharmacokinetics of regimen-related toxicities as well as the obstacles that remain in predicting risk for treatment-related toxicity.
Susan G. Braun, MA, FASCO, is receiving the 2016 Partners in Progress Award for her work in advancing cancer care as the leader of several high-profile cancer organizations, including The Conquer Cancer Foundation® of ASCO, the Susan G. Komen® foundation, and The V Foundation for Cancer Research.